For Patients with Diabetes

Diabetes is one of the world’s prevalent and critical chronic diseases without cure, a life-threatening affliction leading to heart disease, kidney failure, blindness, foot ulcers and amputation.

Currently 10% of adult world population have some form of diabetes. Projections for 2050 are that 1 in 3 people may have diabetes if nothing is done on time.

In the U.S. diabetes affects almost 27 million people and is approaching epidemic growth rates in many countries throughout the world: India 57.1 million, Europe 55.3 million, China 43.1 million, Middle East & North Africa 26.6 million, South America 18 million people affected.

Over 285 million people worldwide have diabetes today, and within the next 10-20 years projections estimate 438 million people will suffer from the disease.

Every 30 seconds someone loses a leg in the world, caused by diabetes complications and 85% of these losses begin with a foot ulceration. Approximately 15% of people with diabetes will develop foot ulcers at least once during their lifetime, an affliction which can escalate to serious infection and amputation due to rising vascular damage. Recurrence of diabetic foot ulcer (DFU) has been reported as high as 70% within 5 years.

Circulat® is a natural restorer of vascular health, a genetic modulator that reverts vascular disease and can prevent amputation in 85% of cases as clinically proven.

Circulat® capsules combine a patented formula of 22 botanical ingredients traditionally described in Complementary and Alternative Medicine (CAM).

For Patients with Heart & Circulatory Diseases

A common serious complication of diabetes is damage to blood vessels leading to decreased blood flow to the heart (cardiac ischemia) that results in chest pain (angina pectoris) and heart attacks. This occurs in 6.6 million patients a year in the U.S. alone, despite the use of established drugs for angina pectoris and some modern surgical procedures — stents, angioplasty, etc.

Obviously, the overall disease burden reflects the many limitations of current therapy, as medication for angina pectoris are only partially effective, with a high morbidity and mortality from invasive procedures.

Almost 2 million people each year continue to suffer from cardiac ischemia and angina attacks, even with current interventions and therapies to optimize revascularization. According to American Heart Association statistics there are 8.5 million heart patients and 10.2 million people suffering from angina pectoris in the U.S.

According to the WHO World Atlas, heart disease and strokes kill 17 million people each year, approximately 29.3% of deaths worldwide. Nearly 40% is specifically for ischemic heart disease.

The herbal formula of Circulat® has shown consistent efficacy for improving vascular pathologies such as micro and macro vascular insufficiencies which are the leading cause of amputations, heart disease, blindness, and painful neuropathy.